153 related articles for article (PubMed ID: 37727481)
1. Novel
Chen YT; Jiang WZ; Lu KD
World J Clin Cases; 2023 Sep; 11(25):5947-5953. PubMed ID: 37727481
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
3. Thin basement membrane nephropathy.
Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review.
Rahimzadeh H; Ajlou S; Nili F; Razeghi E
BMC Nephrol; 2023 Apr; 24(1):97. PubMed ID: 37059980
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel pathogenic
Nie DA; Xia CR; Huang KC; Liu J; Gan T; Wen C; Zeng ZP
Biomed Rep; 2021 Nov; 15(5):90. PubMed ID: 34589218
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report.
Hao W; Ao L; Zhang C; Zhu L; Xie D
J Int Med Res; 2020 Mar; 48(3):300060519891290. PubMed ID: 31840555
[TBL] [Abstract][Full Text] [Related]
7. COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?
Voskarides K; Papagregoriou G; Hadjipanagi D; Petrou I; Savva I; Elia A; Athanasiou Y; Pastelli A; Kkolou M; Hadjigavriel M; Stavrou C; Pierides A; Deltas C
BMC Nephrol; 2018 May; 19(1):114. PubMed ID: 29764427
[TBL] [Abstract][Full Text] [Related]
8. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Identification of a Novel Heterozygous Missense Mutation in
Hu Y; Li W; Tian L; Fu S; Min Y; Liu J; Xiong F
Front Genet; 2022; 13():839212. PubMed ID: 35422838
[TBL] [Abstract][Full Text] [Related]
10. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.
Bhattacharyya A; Huang Y; Khan SH; Drachenberg CB; Malone LC
BMC Nephrol; 2021 Oct; 22(1):358. PubMed ID: 34717572
[TBL] [Abstract][Full Text] [Related]
11. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
[TBL] [Abstract][Full Text] [Related]
12. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
13. Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome.
Akihisa T; Sato M; Wakayama Y; Taneda S; Horita S; Hirose O; Makabe S; Kataoka H; Mori T; Sohara E; Uchida S; Nitta K; Mochizuki T
Kidney Med; 2019; 1(6):391-396. PubMed ID: 32734219
[TBL] [Abstract][Full Text] [Related]
14. [Genetic variants of familial hematuria associated genes in three families with hematuria with probands initially diagnosed as IgA nephropathy].
Liu JW; Wang P; Huang J; Nie XJ; Zhao F; Chen LZ; Li Z; Yu ZH
Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):674-679. PubMed ID: 31530352
[No Abstract] [Full Text] [Related]
15. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
16. A novel variant in the
Sienes Bailo P; Bancalero Flores JL; Lahoz Alonso R; Santamaría González M; Gutiérrez Dalmau A; Álvarez de Andrés S; Izquierdo Álvarez S
Adv Lab Med; 2021 Aug; 2(3):451-462. PubMed ID: 37362409
[TBL] [Abstract][Full Text] [Related]
17. Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.
Ishiko S; Tanaka A; Takeda A; Hara M; Hamano N; Koizumi M; Ueno T; Hayashi H; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Horinouchi T; Yamamura T; Ninchoji T; Shima Y; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
Clin Exp Nephrol; 2021 Jul; 25(7):779-787. PubMed ID: 33743099
[TBL] [Abstract][Full Text] [Related]
18. Familial hematuria: A review.
Plevová P; Gut J; Janda J
Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
[TBL] [Abstract][Full Text] [Related]
19. Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.
Choi M; Anistan YM; Eckardt KU; Gollasch M; Nickel P
Nephron; 2019; 141(3):213-218. PubMed ID: 30661074
[TBL] [Abstract][Full Text] [Related]
20. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
